SHANGHAI, June 15, 2022 /PRNewswire/ — Pulnovo Medical Limited, a globally recognized OTM innovation platform, recently announced that Dr. Krishna Sudhir has officially joined the Pulnovo Medical Scientific Advisory Board. Dr. Krishna Sudhir will provide scientific guidance and take an important part in the innovation and internationalization of Pulnovo Medical’s technology platforms and R&D portfolio. Dr. Sudhir […]
Other News
FLEX Vessel Prep AV Registry Data Shows A Longer Lasting Solution to Stand Alone PTA When Treating AV Access Fistulas and Grafts
MINNEAPOLIS, June 15, 2022 /PRNewswire/ — VentureMed Group, Inc., a privately held medical device innovator in access management for arteriovenous (AV) fistulas and grafts and vessel preparation for interventional treatment of peripheral arterial disease (PAD) announced data presented at the Vascular Access Societies of the Americas (VASA) June 9-11, Charleston, South Carolina. Study Details and FindingsFLEX Vessel […]
Silk Road Medical Announces Post Approval Study for the Treatment of Standard Surgical Risk Patients using TCAR
SUNNYVALE, Calif., June 15, 2022 (GLOBE NEWSWIRE) — Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced a prospective study to evaluate the TCAR® system in the treatment of standard surgical risk patients with carotid artery disease. The post-market […]
BioCardia Announces US Patent on Imaging System for Targeting Cardiac Therapies
SUNNYVALE, Calif., June 15, 2022 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announces that the United States Patent Office has granted Patent Number 11,357,463: titled, “Target Site Selection, Entry and Update With Automatic Remote Image Annotation”, […]
Bodyport Appoints John Lipman as Chief Executive Officer
Medtech industry veteran to lead Bodyport market entry and growth of noninvasive tool to assess heart function and fluid status easily at home SAN FRANCISCO–(BUSINESS WIRE)–Bodyport, a biomarker-guided digital therapeutics company on a mission to address complex chronic conditions, today announced the appointment of medtech industry veteran, John Lipman, as Chief Executive […]
Cardiawave Confirms the Safety of VALVOSOFT® its Non-Invasive Ultrasound Treatment for Aortic Stenosis
– No cerebral vascular anomaly before and after treatment observed – Successful completion of the FIM II clinical study prior to the pivotal study, that will pave the way for CE marking PARIS–(BUSINESS WIRE)–Cardiawave SA, a deeptech medical device manufacturer that has developed VALVOSOFT® a revolutionary non-invasive medical device to treat aortic […]
Hyperfine Announces Expansion into Australia and New Zealand with Medical Device Registration and Notification
Alfred Health to receive first in nation portable MRI systems for point-of-care brain scans GUILFORD, Conn., June 14, 2022 (GLOBE NEWSWIRE) — Hyperfine, Inc. (Nasdaq: HYPR), creator of the Swoop® Portable MR Imaging System™, the world’s first US FDA-cleared portable magnetic resonance imaging (MRI) device, announced today that it has […]
Impulse Dynamics Announces First International Implants of the Optimizer Smart Mini System in Italy
MARLTON, N.J., June 14, 2022 (GLOBE NEWSWIRE) — Impulse Dynamics, a commercial-stage medical device company focused on delivering our CCM therapy to people with heart failure, announced that the first implants in Europe for the newly launched Optimizer® Smart Mini device were recently completed in Italy. The company announced the […]
Cordis-X Makes Strategic Investment in Adient Medical, Developer of First Fully Absorbable Inferior Vena Cava (IVC) Filter
Signals continued investment in accelerated cardiovascular technology development MENLO PARK, Calif., June 14, 2022 /PRNewswire/ — Cordis-X today announced an $11.5 million Series F investment in Adient Medical, maker of a next-generation absorbable inferior vena cava (IVC) filter that provides protection against pulmonary embolisms (PE). The device is designed to avoid well-documented risks of perforation, migration, fracture, […]
Stealth BioTherapeutics Granted Pre-NDA Meeting for Elamipretide as a Potential Treatment for Barth Syndrome
Type B meeting scheduled with FDA Division of Cardiology and Nephrology Company plans to discuss new clinical data that may inform a potential NDA submission BOSTON, June 14, 2022 /PRNewswire/ — Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction, […]



